Marker Therapeutics, Inc. · NASDAQ
Sign up free to see this.
Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
No sentiment yet
At least 5 tagged posts are needed.
How do you feel about MRKR?
Zacks Investment Research
All You Need to Know About MARKER THERAPEUTICS (MRKR) Rating Upgrade to Strong BuyMarker Therapeutics (MRKR) has been upgraded to a Zacks Rank #1 (Strong Buy) rating due to rising earnings estimates. The company's consensus estimate has increased 45.3% over the past three months, positioning it in the top 5% of Zacks-covered stocks. The upgrade reflects an improving business outlook that could drive near-term stock price appreciation.
Headlines link to the publisher. Not investment advice.
No threads yet
Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.
Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
No sentiment yet
Sign in to post on $MRKR
No threads yet
Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.
